Cancer News and Research

Latest Cancer News and Research

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.

23 Feb 2010

Menssana Research develops 85% accurate breath test for pulmonary tuberculosis

A new breath test can detect active pulmonary tuberculosis, according to a report to be published in the journal "Tuberculosis."

23 Feb 2010

Catheter insertion technology patent acquired by Acacia Research subsidiary

Acacia Research Corporation announced today that a subsidiary has acquired patents for catheter insertion technology.

23 Feb 2010

USPSTF mammography recommendations: Avon Foundation for Women survey confirms states denying coverage

A recent Avon Foundation for Women survey confirms what the American College of Radiology and other experts warned would happen: states are using deeply flawed and widely discredited U.S. Preventative Services Task Force mammography recommendations to deny women coverage for mammograms, and many women are foregoing long proven, life-saving mammography care based on the mistaken USPSTF recommendations.

23 Feb 2010

Key mechanism that makes brain cells become tumorous identified

Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.

23 Feb 2010

DNA interval in unexplored region of human genome increases risk for coronary artery disease

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have learned how an interval of DNA in an unexplored region of the human genome increases the risk for coronary artery disease, the leading cause of death worldwide.

23 Feb 2010

Northern Michigan Regional Hospital selects Medicity for implementing HIE

Medicity – the standard for health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care collaboration – today reported that Northern Michigan Regional Hospital has selected Medicity to electronically exchange health information among its hospitals and physicians across the 22 counties it serves. The health system, which was named to the 2009/2010 Most Wired list by Hospitals & Health Networks magazine, cites health information exchange (HIE) as a vital initiative toward realizing its strategic plan for patient-centered care and meeting meaningful use requirements.

23 Feb 2010

ExonHit Therapeutics includes proprietary lead compounds into collaboration with Allergan

ExonHit Therapeutics today announced the inclusion of proprietary lead compounds, which were derived from one of its internal medicinal chemistry programs, into its productive and long-running strategic collaboration with Allergan.

23 Feb 2010

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.

23 Feb 2010

National public service campaign to raise mental health awareness in young African American adults

Officials from the Substance Abuse and Mental Health Services Administration (SAMHSA), the Ad Council and the Stay Strong Foundation will unveil a national public service campaign designed to raise awareness of mental health problems among young adults in the African American community. The event is part of Black History Month and it is being held to coincide with the first annual Historically Black Colleges and Universities National Mental Health Awareness Day. The launch will be telecast to colleges and universities nationwide.

23 Feb 2010

Lilly, Merck, Pfizer collaborate to accelerate research on commonly-diagnosed cancer

Eli Lilly and Company, Merck (also known as Merck Sharp & Dohme (MSD) outside the USA and Canada), and Pfizer Inc. today announced the formation of the Asian Cancer Research Group, Inc., an independent, not-for-profit company established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia.

23 Feb 2010

Head and neck tumors in close proximity to sensitive areas may lead to brain injury, visionary risk or hearing loss

When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.

23 Feb 2010

Combining PARP inhibitors with existing cancer drugs promising

Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.

23 Feb 2010

Multidisciplinary Head and Neck Cancer Symposium in Phoenix

The Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM, will host two news briefings on top head and neck cancer research from its meeting February 25-27, 2010, in Phoenix.

23 Feb 2010

Unique resource for families facing hereditary breast and ovarian cancer

When she was forty-two, Joi Morris learned that she has a genetic mutation on a gene known as BRCA2. This meant that her risk of getting breast cancer could be as high as 84 percent by age seventy, and that her risk for ovarian cancer was also high.

23 Feb 2010

Varian Medical Systems wins 100th X-ray tube patent

Varian Medical Systems, Inc., a premier supplier of X-ray tubes and flat panel digital image detectors, announced it has been awarded a patent for improved shielding in X-ray tubes. It is the company's 100th X-ray tube patent from the United States Patent Office.

23 Feb 2010

Combination of MRI and mammography reduces mortality rate in high-risk women

Annual breast cancer screening with both mammography and magnetic resonance imaging (MRI) is likely to be a cost-effective way to improve life expectancy in women with an increased risk of breast cancer, according to a new study published in the March issue of Radiology.

23 Feb 2010

Green Smoke claims e-cigarettes are healthy alternative to traditional tobacco

The controversy surrounding electronic cigarettes and the FDA continues. As reported by CNN, New York Times and USA Today, the FDA lost its first battle against e-cigarettes in a federal court and is appealing the ruling.

23 Feb 2010

Epicept issues amendment for reduction in company's quorum requirement

EpiCept Corporation announced today that on February 11, 2010, the Board of Directors of EpiCept Corporation adopted an amendment to the company’s Amended and Restated By-Laws to provide that a quorum for the transaction of business at any meeting of the stockholders of the Company shall consist of the holders of one third of the issued and outstanding shares of common stock of the Company.

23 Feb 2010

Study shows CEL-2000 vaccine blocks RA progression in mice

CEL-SCI Corporation and their scientific collaborators announced today that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model.

23 Feb 2010

Cancer News and Research

Latest Cancer News and Research

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

Menssana Research develops 85% accurate breath test for pulmonary tuberculosis

Catheter insertion technology patent acquired by Acacia Research subsidiary

USPSTF mammography recommendations: Avon Foundation for Women survey confirms states denying coverage

Key mechanism that makes brain cells become tumorous identified

DNA interval in unexplored region of human genome increases risk for coronary artery disease

Northern Michigan Regional Hospital selects Medicity for implementing HIE

ExonHit Therapeutics includes proprietary lead compounds into collaboration with Allergan

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

National public service campaign to raise mental health awareness in young African American adults

Lilly, Merck, Pfizer collaborate to accelerate research on commonly-diagnosed cancer

Head and neck tumors in close proximity to sensitive areas may lead to brain injury, visionary risk or hearing loss

Combining PARP inhibitors with existing cancer drugs promising

Multidisciplinary Head and Neck Cancer Symposium in Phoenix

Unique resource for families facing hereditary breast and ovarian cancer

Varian Medical Systems wins 100th X-ray tube patent

Combination of MRI and mammography reduces mortality rate in high-risk women

Green Smoke claims e-cigarettes are healthy alternative to traditional tobacco

Epicept issues amendment for reduction in company's quorum requirement

Study shows CEL-2000 vaccine blocks RA progression in mice

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in